BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38319449)

  • 1. CD36 inhibition reduces non-small-cell lung cancer development through AKT-mTOR pathway.
    Liu H; Guo W; Wang T; Cao P; Zou T; Peng Y; Yan T; Liao C; Li Q; Duan Y; Han J; Zhang B; Chen Y; Zhao D; Yang X
    Cell Biol Toxicol; 2024 Feb; 40(1):10. PubMed ID: 38319449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The activated CD36-Src axis promotes lung adenocarcinoma cell proliferation and actin remodeling-involved metastasis in high-fat environment.
    Liu LZ; Wang B; Zhang R; Wu Z; Huang Y; Zhang X; Zhou J; Yi J; Shen J; Li MY; Dong M
    Cell Death Dis; 2023 Aug; 14(8):548. PubMed ID: 37612265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of vitamin D on malignant behavior of non-small cell lung cancer cells.
    Songyang Y; Song T; Shi Z; Li W; Yang S; Li D
    Gene; 2021 Feb; 768():145309. PubMed ID: 33197518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hematopoietic cell-restricted deletion of CD36 reduces high-fat diet-induced macrophage infiltration and improves insulin signaling in adipose tissue.
    Nicholls HT; Kowalski G; Kennedy DJ; Risis S; Zaffino LA; Watson N; Kanellakis P; Watt MJ; Bobik A; Bonen A; Febbraio M; Lancaster GI; Febbraio MA
    Diabetes; 2011 Apr; 60(4):1100-10. PubMed ID: 21378177
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel PI3K inhibitor S1 synergizes with sorafenib in non-small cell lung cancer cells involving the Akt-S6 signaling.
    Wang J; Ma S; Chen X; Zhang S; Wang Z; Mei Q
    Invest New Drugs; 2019 Oct; 37(5):828-836. PubMed ID: 30456603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory Antibodies against PCSK9 Reduce Surface CD36 and Mitigate Diet-Induced Renal Lipotoxicity.
    Byun JH; Lebeau PF; Platko K; Carlisle RE; Faiyaz M; Chen J; MacDonald ME; Makda Y; Yousof T; Lynn EG; Dickhout JG; Krepinsky JC; Weaver F; Igdoura SA; Seidah NG; Austin RC
    Kidney360; 2022 Aug; 3(8):1394-1410. PubMed ID: 36176646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SIRT6 through PI3K/Akt/mTOR signaling pathway to enhance radiosensitivity of non-Small cell lung cancer and inhibit tumor progression.
    Xiong L; Tan B; Lei X; Zhang B; Li W; Liu D; Xia T
    IUBMB Life; 2021 Sep; 73(9):1092-1102. PubMed ID: 34033225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NFV, an HIV-1 protease inhibitor, induces growth arrest, reduced Akt signalling, apoptosis and docetaxel sensitisation in NSCLC cell lines.
    Yang Y; Ikezoe T; Nishioka C; Bandobashi K; Takeuchi T; Adachi Y; Kobayashi M; Takeuchi S; Koeffler HP; Taguchi H
    Br J Cancer; 2006 Dec; 95(12):1653-62. PubMed ID: 17133272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesterol-lowering drug pitavastatin targets lung cancer and angiogenesis via suppressing prenylation-dependent Ras/Raf/MEK and PI3K/Akt/mTOR signaling.
    Hu T; Shen H; Huang H; Yang Z; Zhou Y; Zhao G
    Anticancer Drugs; 2020 Apr; 31(4):377-384. PubMed ID: 32011362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empagliflozin Ameliorates Free Fatty Acid Induced-Lipotoxicity in Renal Proximal Tubular Cells via the PPARĪ³/CD36 Pathway in Obese Mice.
    Huang CC; Chou CA; Chen WY; Yang JL; Lee WC; Chen JB; Lee CT; Li LC
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inflammatory stress promotes the development of obesity-related chronic kidney disease via CD36 in mice.
    Yang P; Xiao Y; Luo X; Zhao Y; Zhao L; Wang Y; Wu T; Wei L; Chen Y
    J Lipid Res; 2017 Jul; 58(7):1417-1427. PubMed ID: 28536108
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Curcumin inhibits migration and invasion of non-small cell lung cancer cells through up-regulation of miR-206 and suppression of PI3K/AKT/mTOR signaling pathway.
    Wang N; Feng T; Liu X; Liu Q
    Acta Pharm; 2020 Sep; 70(3):399-409. PubMed ID: 32074070
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Palmitate aggravates proteinuria-induced cell death and inflammation via CD36-inflammasome axis in the proximal tubular cells of obese mice.
    Li LC; Yang JL; Lee WC; Chen JB; Lee CT; Wang PW; Vaghese Z; Chen WY
    Am J Physiol Renal Physiol; 2018 Dec; 315(6):F1720-F1731. PubMed ID: 30230367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GDC-0349 inhibits non-small cell lung cancer cell growth.
    Yang H; Zhao J; Zhao M; Zhao L; Zhou LN; Duan Y; Li G
    Cell Death Dis; 2020 Nov; 11(11):951. PubMed ID: 33154352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Luteoloside induces G
    Zhou M; Shen S; Zhao X; Gong X
    Biochem Biophys Res Commun; 2017 Dec; 494(1-2):263-269. PubMed ID: 29024631
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hydroxysafflor yellow A inhibited lipopolysaccharide-induced non-small cell lung cancer cell proliferation, migration, and invasion by suppressing the PI3K/AKT/mTOR and ERK/MAPK signaling pathways.
    Jiang M; Zhou LY; Xu N; An Q
    Thorac Cancer; 2019 Jun; 10(6):1319-1333. PubMed ID: 31055884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Jervine inhibits non-small cell lung cancer (NSCLC) progression by suppressing Hedgehog and AKT signaling via triggering autophagy-regulated apoptosis.
    Lei W; Huo Z
    Biochem Biophys Res Commun; 2020 Dec; 533(3):397-403. PubMed ID: 32972750
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An-te-xiao capsule inhibits tumor growth in non-small cell lung cancer by targeting angiogenesis.
    Han L; Wang JN; Cao XQ; Sun CX; Du X
    Biomed Pharmacother; 2018 Dec; 108():941-951. PubMed ID: 30372906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAM83D promotes epithelial-mesenchymal transition, invasion and cisplatin resistance through regulating the AKT/mTOR pathway in non-small-cell lung cancer.
    Yin C; Lin X; Wang Y; Liu X; Xiao Y; Liu J; Snijders AM; Wei G; Mao JH; Zhang P
    Cell Oncol (Dordr); 2020 Jun; 43(3):395-407. PubMed ID: 32006253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardamonin inhibits the proliferation and metastasis of non-small-cell lung cancer cells by suppressing the PI3K/Akt/mTOR pathway.
    Zhou X; Zhou R; Li Q; Jie X; Hong J; Zong Y; Dong X; Zhang S; Li Z; Wu G
    Anticancer Drugs; 2019 Mar; 30(3):241-250. PubMed ID: 30640793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.